000			01669 a2200457 4500
005			20250516052513.0
264		0	_c20120208
008			201202s 0 0 eng d
022			_a1872-9096
024	7		_a10.1016/j.antiviral.2011.08.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aDroebner, Karoline
245	0	0	_aAntiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo. _h[electronic resource]
260			_bAntiviral research _cNov 2011
300			_a195-203 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aButadienes _xadministration & dosage
650	0	4	_aCell Line
650	0	4	_aCell Survival
650	0	4	_aDisease Models, Animal
650	0	4	_aDogs
650	0	4	_aEnzyme Inhibitors _xadverse effects
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInfluenza A virus _xdrug effects
650	0	4	_aLung _xvirology
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMicrobial Sensitivity Tests
650	0	4	_aMitogen-Activated Protein Kinase Kinases _xantagonists & inhibitors
650	0	4	_aNitriles _xadministration & dosage
650	0	4	_aOrthomyxoviridae Infections _xprevention & control
650	0	4	_aSurvival Analysis
700	1		_aPleschka, Stephan
700	1		_aLudwig, Stephan
700	1		_aPlanz, Oliver
773	0		_tAntiviral research _gvol. 92 _gno. 2 _gp. 195-203
856	4	0	_uhttps://doi.org/10.1016/j.antiviral.2011.08.002 _zAvailable from publisher's website
999			_c21098144 _d21098144